Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report

Goossens, Nicolas; Spahr, Laurent François Joséph; Rubbia-Brandt, Laura

doi:10.1016/j.jhep.2013.06.003

Scientific article

Case report

English

Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report

ContributorsGoossens, Nicolas; Spahr, Laurent François Joséph; Rubbia-Brandt, Laura

Published inJournal of Hepatology, vol. 59, no. 5, p. 1139-1142

Publication date2013

Abstract

Ibandronate is a widely used bisphosphonate with no previously well documented hepatotoxicity. We report the first case of ibandronate-related hepatotoxicity and, to our knowledge, the first case of immune-mediated drug-induced liver injury (DILI) related to bisphosphonates.

Affiliation entities

Research groups

Métastases du foie (657)

Citation (ISO format)

GOOSSENS, Nicolas, SPAHR, Laurent François Joséph, RUBBIA-BRANDT, Laura. Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report. In: Journal of Hepatology, 2013, vol. 59, n° 5, p. 1139–1142. doi: 10.1016/j.jhep.2013.06.003

Article (Accepted version)

Identifiers

PID : unige:33459
DOI : 10.1016/j.jhep.2013.06.003
PMID : 23770145

632views

0downloads

Creation20/01/2014 11:47:00

First validation20/01/2014 11:47:00

Update14/03/2023 20:52:20

Status update14/03/2023 20:52:20

Last indexation30/10/2024 15:57:04

Archive ouverte UNIGE

Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report

Ibandronate is a widely used bisphosphonate with no previously well documented hepatotoxicity. We report the first case of ibandronate-related hepatotoxicity and, to our knowledge, the first case of immune-mediated drug-induced liver injury (DILI) related to bisphosphonates.

Technical informations